NCT04277377View on ClinicalTrials.gov

Nanoparticle for DSA Removal

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 5, 2021

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Kidney FailurePresence of Donor Specific Antibodies
Trial Locations (1)

8091

University Hospital Zurich, Division of Anaesthesiology, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER